Shots: The first patient has been dosed in the P-I ANTLER trial evaluating CB-010 in patients with r/r B-NHL. In the dose-escalation part of the study, patients who have failed […]readmore
Tags : First Patient Dosing
Shots: The first patient has been dosed in a P-II/III clinical trial of HLX10 in combination with HLX04 (bevacizumab) and CT for 1L treatment of mCRC The combination regimen aims […]readmore
Shots: The company has reported the first patient dosing in P-l study assessing the safety, tolerability, and immunogenicity of HLX11 vs US-, EU- and China-sourced reference pertuzumab in healthy Chinese […]readmore
Shots: The first patient has been dosed in the P-IIa expansion portion of P- I/IIa study, assessing BT1718 (qw) at RP2D of 20 mg/m2 in patients with MT1-MMP+ sq. NSCLC […]readmore
Shots:Shots: The Phase 1/2 study assesses the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion of […]readmore
Shots: The P-I/II study will assess the safety & efficacy of AGN-151587 (subretinal injection) in ~18 patients with Leber congenital amaurosis 10. The patients enrolled are both adult & pediatric […]readmore